Compare OIO & BDTX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | OIO | BDTX |
|---|---|---|
| Founded | 1999 | 2014 |
| Country | Cayman Islands | United States |
| Employees | N/A | N/A |
| Industry | Environmental Services | Biotechnology: Biological Products (No Diagnostic Substances) |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 139.7M | 116.8M |
| IPO Year | N/A | 2020 |
| Metric | OIO | BDTX |
|---|---|---|
| Price | $1.58 | $2.71 |
| Analyst Decision | | Strong Buy |
| Analyst Count | 0 | 7 |
| Target Price | N/A | ★ $9.50 |
| AVG Volume (30 Days) | 87.2K | ★ 817.7K |
| Earning Date | 05-01-2026 | 05-08-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 130.71 |
| EPS | N/A | ★ 0.39 |
| Revenue | N/A | N/A |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | N/A | N/A |
| P/E Ratio | ★ N/A | $7.51 |
| Revenue Growth | N/A | N/A |
| 52 Week Low | $1.90 | $1.46 |
| 52 Week High | $7.50 | $4.94 |
| Indicator | OIO | BDTX |
|---|---|---|
| Relative Strength Index (RSI) | 29.16 | 49.90 |
| Support Level | N/A | $2.45 |
| Resistance Level | $3.34 | $2.79 |
| Average True Range (ATR) | 0.66 | 0.20 |
| MACD | -0.12 | -0.01 |
| Stochastic Oscillator | 1.00 | 28.64 |
Black Diamond Therapeutics Inc is a clinical-stage oncology company developing MasterKey therapies that target families of oncogenic mutations in patients with cancer. It is engaged in the discovery and development of small molecule, tumor-agnostic therapies. The company has one pipeline technology platform, namely Mutation-Allostery-Pharmacology, which is targeting mutations in cancer. Its drugs under the pipeline are BDTX-4933 and BDTX-1535.